Endoscopic Transfer of Flexor Hallucis Longus Tendon for Chronic Achilles Tendon Rupture

NCT ID: NCT02996253

Last Updated: 2023-03-22

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 38 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2015-12-31
• Study Completion Date: 2024-02-29

Brief Summary

The transfer of Flexor Hallucis Longus (FHL) in the management of chronic Achilles tendon ruptures has demonstrated good functional outcome, but an extensive surgical field at a vulnerable location may lead to increased risk for soft tissue problems. The arthroscopic FHL transfer may reduce the risk for soft tissue problems. Functional outcome parameters are investigated, wound/soft tissue complications registered.

Detailed Description

The transfer of FHL in the management of chronic Achilles tendon ruptures has demonstrated good functional outcome with American Orthopaedic Foot ane Ankle Society (AOFAS) hindfoot scores at 80-89. The extensive surgical field by either a two-incision approach or a single longitudinal posterior approach to the Achilles tendon may lead to an increased risk for soft tissue problems, both infections and wound healing problems. The endoscopic FHL transfer may reduce the risk for soft tissue problems while retaining a good functional outcome. Several functional outcome measures and scores are evaluated a year after surgery.

Prospective study for evaluation of the surgical procedure.

Conditions

Achilles Tendon Rupture

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Interventions

FHL transfer

endoscopic transfer og flexor hallucis longus

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Chronic Achilles Tendon Rupture

Exclusion Criteria

• Pregnancy
• BMI<18.5 or >39.9
• Insufficient Norwegian Language proficiency lack of communication skills local skin conditions at site for planned surgery

• Minimum Eligible Age: 30 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Central Hospital, Fredrikstad

UNKNOWN

Sponsor Role: collaborator

Oslo University Hospital

OTHER

Sponsor Role: lead

Responsible Party

Elisabeth Ellingsen Husebye

MD, PhD

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Elisabeth E Husebye, MD, PhD

Role: STUDY_CHAIR

Oslo University Hospital

Locations

Oslo University Hospital

Oslo, , Norway

Countries

Norway

Other Identifiers

2015/16389

Identifier Type: -

Identifier Source: org_study_id